Air France CEO Criticizes Paris Airport Over Parking Shortageby Mark Eisenberg 20.06.2024"Air France-KLM CEO Ben Smith urges ADP to improve Charles de Gaulle Airport, citing jetway shortages, border control, and baggage ...
Amazon Pumps €10B More into Germany Amid Cloud Rivalryby Mark Eisenberg 19.06.2024Amazon announced a €10B investment in Germany, focusing on cloud computing, logistics, and job creation, strengthening its European presence.
Google Invests $2.3B in Ohio Tech Hub, Strengthens AI in Europeby Mark Eisenberg 19.06.2024Google invests $2.3B to expand Ohio's data centers, marking the state's rise as a key tech hub and boosting AI ...
Qualcomm Agrees to $75M Settlement Over Licensing Practicesby Mark Eisenberg 19.06.2024Qualcomm settles for $75M with shareholders over hidden sales practices; awaits judge's approval. Significant impact on investor trust and market ...
Nvidia Tops Microsoft as World’s Most Valuable Companyby Mark Eisenberg 19.06.2024Nvidia surpasses Microsoft to become world's most valuable company, driven by AI boom; dominates Wall Street trading and market value.
Virtual Reality Exposure Therapy Market: Transforming Anxiety Treatmentby Lilu Anderson 18.06.2024Discover the booming VRET market, driven by tech advances and mental health needs, expected to grow at a 33.90% CAGR ...
Kansas Eyes Chiefs Move with New Stadium Planby John Darbie 18.06.2024Kansas lawmakers aim to lure the Super Bowl champion Kansas City Chiefs from Missouri with a new stadium plan, reigniting ...
Ethereum Set to Surge 50% Amid BTC Rivalry & ETF Approvalby John Darbie 18.06.2024Ethereum could surge 50% vs. Bitcoin in 2023, driven by the inverse head-and-shoulders pattern and Spot Ethereum ETF approvals. Stay ...
High Tide Reports Growth Amid Cannabis Sector Challengesby Mark Eisenberg 17.06.2024High Tide Inc. reports 5% revenue growth & 111% same-store sales boost amid cannabis sector challenges, thanks to its unique ...
Roche’s Hemlibra Battles Fierce Competition Amid Rating Holdby Mark Eisenberg 17.06.2024Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...